Showing 692 news articles about New & experimental HIV treatments

Filters Content type: Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Gilead's Investigational Antiretroviral Quad Regimen Non-Inferior at 48 weeks in Phase 3 Study

Editor's pick
Press release
15 August 2011
Epidemiology

HIV Cure - NIH Funding Will Back More Research

Editor's pick
Your-Story.org
15 August 2011
New & experimental HIV treatments

HIV/AIDS researcher David Ho wins NIDA's 2011 Avant-Garde Award

Editor's pick
NIH
12 August 2011
New & experimental HIV treatments

Sugar-binding protein may play a role in HIV infection

Editor's pick
Science Daily
11 August 2011
New & experimental HIV treatments

U.S. Food and Drug Administration Approves Gilead Science's Complera

Editor's pick
Drugs.com
11 August 2011
New & experimental HIV treatments

Scientist develops virus that targets HIV: Using a virus to kill a virus

Editor's pick
Moreover.com HIV/AIDS feed
8 August 2011
New & experimental HIV treatments

Vacc-4x Reduces Viral Load in HIV Patients Off ART

Editor's pick
Medscape (requires registration)
26 July 2011
New & experimental HIV treatments

AIDS: No hiding place

Editor's pick
The Economist
22 July 2011
New & experimental HIV treatments

Abbott Confirms Long-Term Commitment to HIV Care with the Planned Development ... - istockAnalyst.com (press release)

Editor's pick
Abbott
15 July 2011
New & experimental HIV treatments

HIV, Hep C Drug Development Pipeline is 'Robust,' Says Report

Editor's pick
Poz magazine news
15 July 2011
Pharmaceutical industry

Gilead Licence Expands Access, But Several Countries Left Out

Editor's pick
MSF
12 July 2011
Pharmaceutical industry

Gilead licenses four HIV drugs to Medicines Patent Pool

Editor's pick
Medicines Patent Pool
12 July 2011
Pharmaceutical industry

Gilead kickstarts patent pool for AIDS drugs

Editor's pick
Reuters
12 July 2011
New & experimental HIV treatments

Gladstone Institute to receive $5.6 million in federal funds to seek a cure for AIDS

Editor's pick
Eurekalert Medicine & Health
11 July 2011
New & experimental HIV treatments

Merck, Sangamo to Gain From $70 Million Boost in AIDS Cure Hunt

Editor's pick
Bloomberg
11 July 2011
New & experimental HIV treatments

NIH funds new research toward an HIV cure

Editor's pick
Eurekalert Medicine & Health
11 July 2011
Exposure to HIV through medical procedures

Hemophilia is Target of Therapy on Genome

Editor's pick
New York Times
27 June 2011
New & experimental HIV treatments

Tobira Therapeutics Inc. Initiates Phase IIb Trial of Cenicriviroc, a Novel CCR5/CCR2 Antagonist for the Treatment of HIV Infection

Editor's pick
Tobira
22 June 2011
Pharmaceutical industry

Concert Pharmaceuticals Announces Milestone Achievement in GlaxoSmithKline Collaboration

Editor's pick
Concert Pharmaceuticals
22 June 2011
Pharmaceutical industry

Concert Pharma gets $4M from GlaxoSmithKline for HIV drug candidate

Editor's pick
Bizjournals.com
20 June 2011
New & experimental HIV treatments

Learning Lessons from an HIV Cure

Editor's pick
University of California, San Francisco
16 June 2011
New & experimental HIV treatments

With Koronis, Is A Cure For HIV On The Horizon?

Editor's pick
Forbes
13 June 2011
Pharmaceutical industry

Synageva Merges with Trimeris in All-Stock Deal

Editor's pick
Genetic Engineering & Biotechnology News
13 June 2011
New & experimental HIV treatments

Françoise Barré-Sinoussi: Toward an H.I.V. Cure

Editor's pick
New York Times
5 June 2011